Kristina K.Cercone (Kristi)

Associate

(T) 1.312.269.1587

Kristi Cercone represents clients in all phases of litigation and alternative dispute resolution and focuses her practice on the defense of product liability and mass tort cases involving pharmaceutical and medical device companies. In addition to her mass tort experience, Kristi regularly represents clients in matters before the U.S. Consumer Products Safety Commission and the National Highway Traffic Safety Administration and advises clients on risk minimization, regulatory reporting obligations, warranties, and CPSC product recalls.

Kristi also has represented companies facing data privacy and cybersecurity-related litigation and regulatory inquiries and counsels clients on data collection, use, security, and disclosure policies.

Kristi has significant experience addressing the unique litigation issues facing the pharmaceutical and medical device industries, including those related to the highly regulated environment they operate in and the specialized body of case law that has developed relating to those product liability claims. Prior to joining Jones Day in 2014, Kristi defended a major pharmaceutical company against mass tort product liability allegations in both multidistrict litigation and related proceedings in several states.

Kristi maintains an active pro bono practice, having represented clients through Cabrini Green Legal Aid, the National Immigrant Justice Center, as well as other clients in need. She currently serves as chair of the Grant Park Music Festival's Associates Council.

Experience

  • Takeda defends product liability claims related to pharmaceutical product ActosJones Day is defending Takeda Pharmaceuticals North America, Inc. and Takeda Pharmaceuticals Company Limited as trial counsel in over 3000 suits pending in a consolidated proceeding in Cook County, Illinois related to its Type 2 diabetes drug, Actos.
  • Cardinal Health acquires Cordis for $1.9 billionJones Day advised Cardinal Health, Inc. in its acquisition of Johnson & Johnson's Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $1.9 billion in cash.
  • Cardinal Health acquires The Harvard Drug Group for $1.115 billionJones Day advised Cardinal Health in its acquisition of The Harvard Drug Group, a distributor of generic pharmaceuticals, over-the-counter medications, and related products to retail, institutional, and alternate care customers from Court Square Capital Partners for $1.115 billion.
  • Speaking Engagements

    • May 5, 2016
      Office of the Governor - General Counsel's Office, CLE panelist, Supreme Court Review: October Term 2015 and Beyond
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.